PL3254669T3 - Kosmetyczne zastosowanie N-podstawionych sulfonyloksybenzyloamin i związków powiązanych - Google Patents

Kosmetyczne zastosowanie N-podstawionych sulfonyloksybenzyloamin i związków powiązanych

Info

Publication number
PL3254669T3
PL3254669T3 PL17183427T PL17183427T PL3254669T3 PL 3254669 T3 PL3254669 T3 PL 3254669T3 PL 17183427 T PL17183427 T PL 17183427T PL 17183427 T PL17183427 T PL 17183427T PL 3254669 T3 PL3254669 T3 PL 3254669T3
Authority
PL
Poland
Prior art keywords
related compounds
cosmetic use
sulfonyloxybenzylamines
substituted
substituted sulfonyloxybenzylamines
Prior art date
Application number
PL17183427T
Other languages
English (en)
Inventor
Dmitri S Ptchelintsev
John W Lyga
Russell J Wyborski
Qian Zheng
Cheng S Hwang
Original Assignee
Avon Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Avon Prod Inc filed Critical Avon Prod Inc
Publication of PL3254669T3 publication Critical patent/PL3254669T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/63—Esters of sulfonic acids
    • C07C309/64—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms
    • C07C309/65—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms of a saturated carbon skeleton
    • C07C309/66—Methanesulfonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A61K8/466—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfonic acid derivatives; Salts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PL17183427T 2010-06-30 2011-06-13 Kosmetyczne zastosowanie N-podstawionych sulfonyloksybenzyloamin i związków powiązanych PL3254669T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US12/826,864 US8815265B2 (en) 2010-06-30 2010-06-30 Cosmetic use of N-substituted sulfonyloxybenzylamines and related compounds
PCT/US2011/040141 WO2012005872A1 (en) 2010-06-30 2011-06-13 Cosmetic use of n-substituted solfonyloxybenzylamines and related compounds
EP11804008.8A EP2588460B1 (en) 2010-06-30 2011-06-13 Cosmetic use of n-substituted solfonyloxybenzylamines and related compounds
EP17183427.8A EP3254669B1 (en) 2010-06-30 2011-06-13 Cosmetic use of n-substituted sulfonyloxybenzylamines and related compounds

Publications (1)

Publication Number Publication Date
PL3254669T3 true PL3254669T3 (pl) 2019-11-29

Family

ID=45400170

Family Applications (2)

Application Number Title Priority Date Filing Date
PL11804008T PL2588460T3 (pl) 2010-06-30 2011-06-13 Kosmetyczne zastosowanie N-podstawionych sulfonyloksybenzyloamin i związków powiązanych
PL17183427T PL3254669T3 (pl) 2010-06-30 2011-06-13 Kosmetyczne zastosowanie N-podstawionych sulfonyloksybenzyloamin i związków powiązanych

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL11804008T PL2588460T3 (pl) 2010-06-30 2011-06-13 Kosmetyczne zastosowanie N-podstawionych sulfonyloksybenzyloamin i związków powiązanych

Country Status (13)

Country Link
US (2) US8815265B2 (pl)
EP (2) EP2588460B1 (pl)
JP (1) JP6075733B2 (pl)
CN (1) CN102869649B (pl)
AR (1) AR081788A1 (pl)
BR (1) BR112012028648B1 (pl)
CA (1) CA2794129C (pl)
ES (2) ES2643632T3 (pl)
MX (1) MX347848B (pl)
PL (2) PL2588460T3 (pl)
TR (1) TR201910526T4 (pl)
TW (1) TWI552764B (pl)
WO (1) WO2012005872A1 (pl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011087654A1 (en) 2009-12-22 2011-07-21 Avon Products, Inc. Paxillin stimulating compositions and cosmetic uses thereof
US20110159125A1 (en) 2009-12-29 2011-06-30 Avon Products, Inc. CGRP Compositions and Uses Thereof
BR112012032082B1 (pt) 2010-06-30 2019-11-26 Avon Products, Inc. Composição e método cosmético para melhorar a aparência estética da pele humana
US8815265B2 (en) * 2010-06-30 2014-08-26 Avon Products, Inc. Cosmetic use of N-substituted sulfonyloxybenzylamines and related compounds
US8455518B2 (en) * 2010-12-28 2013-06-04 Avon Products, Inc. Method of treating skin with microRNA modulators
US20120171133A1 (en) * 2010-12-30 2012-07-05 Avon Products, Inc. Modulation of Dynein in Skin
US10195136B2 (en) 2011-08-24 2019-02-05 Avon Products, Inc. Collagen and elastin stimulating compositions and uses thereof
WO2014092686A1 (en) * 2012-12-11 2014-06-19 Avon Products, Inc. Stephanotis jasminoides extracts and methods of use
US9186316B2 (en) 2012-12-11 2015-11-17 Avon Products, Inc. Stephanotis jasminoides extracts and methods of use
TW201422246A (zh) 2012-12-11 2014-06-16 Avon Prod Inc 藉由調節ｗｉｐｉ－１改善皮膚老化外觀之方法
US9345659B2 (en) 2012-12-11 2016-05-24 Avon Products, Inc. Use of melicope extracts to improve conditions caused by excess lipids
US20150359731A1 (en) * 2013-03-14 2015-12-17 Avon Products, Inc Phyllanthus acidus extracts and methods of use
CA2960680A1 (en) * 2014-09-12 2016-03-17 Avon Products, Inc. Moldable mascara comprising an opaque wax, a gellant, a particulate, and an oil

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4122029A (en) 1977-07-27 1978-10-24 Dow Corning Corporation Emulsion compositions comprising a siloxane-oxyalkylene copolymer and an organic surfactant
US4781917A (en) 1987-06-26 1988-11-01 The Proctor & Gamble Company Antiperspirant gel stick
DE19737327A1 (de) * 1997-08-27 1999-03-04 Haarmann & Reimer Gmbh Hydroxyzimtsäureamide hydroxysubstituierter aromatischer Amine
US6685952B1 (en) 1999-06-25 2004-02-03 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Personal care compositions and methods-high internal phase water-in-volatile silicone oil systems
GB9918023D0 (en) 1999-07-30 1999-09-29 Unilever Plc Skin care composition
US20030059450A1 (en) * 2001-09-24 2003-03-27 Maibach Howard I. Method and topical formulation for treating skin conditions associated with aging
AU2002340407A1 (en) 2001-11-09 2003-05-26 Vector Tobacco Inc. Method and composition for mentholation of charcoal filtered cigarettes
US6824786B2 (en) * 2001-11-27 2004-11-30 Ruey J. Yu Compositions comprising phenyl-glycine derivatives
UA82835C2 (en) 2001-12-03 2008-05-26 Reddys Lab Ltd Dr ?-aryl-?-oxysubstituted propionuc acid derivatives and pharmaceutical composition based thereon
US20040105875A1 (en) * 2002-10-03 2004-06-03 L'oreal Composition containing a secondary or tertiary carbonyl amine, method of use thereof, compounds
EP1648403B1 (en) 2003-05-20 2012-08-15 Sederma Slimming cosmetic composition comprising cafestol or kahweol
JP4527451B2 (ja) 2004-06-14 2010-08-18 ビーエーエスエフ ビューティ ケア ソリューションズ フランス エスエーエス 弾性繊維の形成を刺激するための、ｌｏｘｌ（リシルオキシダーゼ類似）アイソフォームの合成及び活性の刺激
JP4954450B2 (ja) 2004-06-14 2012-06-13 ビーエーエスエフ ビューティ ケア ソリューションズ フランス エスエーエス 弾性繊維形成の不全、欠損又は無秩序による病状に対処するための、リシルオキシダーゼのアイソフォームの活性の誘導
KR20060066624A (ko) 2004-10-20 2006-06-16 주식회사 두산 포스파티딜세린을 함유하는 피부 보호 및 개선용 또는 피부장벽 기능 강화용 조성물
BRPI0406040B1 (pt) 2004-10-21 2018-09-11 Universidade Federal Do Rio De Janeiro - Ufrj compostos capazes de absorver radiação ultravioleta, composições contendo os mesmos e processos para sua preparação
WO2006091862A2 (en) 2005-02-24 2006-08-31 Kemia, Inc. Cytokine inhibitors and their use in therapy
DE102005018191A1 (de) 2005-04-19 2006-10-26 Grünenthal GmbH Substituierte zyklische Harnstoff-Derivate und deren Verwendung zur Herstellung von Arzneimitteln
US7928127B2 (en) 2005-05-19 2011-04-19 Notre Dame University Inhibitors of matrix metallaproteinases
JP2007026356A (ja) 2005-07-21 2007-02-01 Sony Corp 情報処理装置、この情報処理装置における処理方法およびその方法をコンピュータに実行させるプログラム
EP2452686A3 (en) 2005-08-29 2012-09-05 HealOr Ltd. Methods and compositions for prevention and treatment of diabetic and aged skin
WO2007029982A1 (en) * 2005-09-08 2007-03-15 Amorepacific Corporation Composition of skin external application for anti-aging
US7060849B1 (en) 2005-09-15 2006-06-13 General Electric Company Method for production of isocyanatosilanes
KR100659138B1 (ko) 2005-09-16 2006-12-19 (주)아모레퍼시픽 유효성분으로 갈로카테킨 갈레이트를 함유하는 보습용피부외용제 조성물
US20070185038A1 (en) 2005-09-30 2007-08-09 The Procter & Gamble Company Regulation of mammalian keratinous tissue using skin care actives
WO2007058990A2 (en) 2005-11-14 2007-05-24 Kemia, Inc. Therapy using cytokine inhibitors
US20100249234A1 (en) 2007-04-10 2010-09-30 Uwm Research Foundation, Inc. Methods of reducing virulence in bacteria
ES2621161T3 (es) 2007-07-31 2017-07-03 The Board Of Regents Of The University Of Texas System Familia de micro-ARN que modula la fibrosis y usos de la misma
EP2197409A1 (en) * 2007-08-31 2010-06-23 DSM IP Assets B.V. 4-amidino benzylamines for cosmetic and/or dermatological use
EP2623101B1 (en) 2009-04-02 2021-04-21 Merck Patent GmbH Piperidine and piperazine derivatives as autotaxin inhibitors
JP6059859B2 (ja) 2009-11-16 2017-01-11 ビーエーエスエフ ビューティ ケア ソリューションズ フランス エスエーエスＢＡＳＦ Ｂｅａｕｔｙ Ｃａｒｅ Ｓｏｌｕｔｉｏｎｓ Ｆｒａｎｃｅ Ｓ．Ａ．Ｓ． 弾性繊維の形成を刺激するための、ｌｏｘｌ（リシルオキシダーゼ類似）アイソフォームの合成及び活性の刺激
US8815265B2 (en) 2010-06-30 2014-08-26 Avon Products, Inc. Cosmetic use of N-substituted sulfonyloxybenzylamines and related compounds
BR112012032082B1 (pt) * 2010-06-30 2019-11-26 Avon Products, Inc. Composição e método cosmético para melhorar a aparência estética da pele humana
US8455518B2 (en) * 2010-12-28 2013-06-04 Avon Products, Inc. Method of treating skin with microRNA modulators
US20120171133A1 (en) 2010-12-30 2012-07-05 Avon Products, Inc. Modulation of Dynein in Skin

Also Published As

Publication number Publication date
EP3254669B1 (en) 2019-04-17
US20140329898A1 (en) 2014-11-06
BR112012028648A2 (pt) 2015-09-15
EP2588460B1 (en) 2017-08-09
EP3254669A1 (en) 2017-12-13
CN102869649A (zh) 2013-01-09
AR081788A1 (es) 2012-10-17
JP6075733B2 (ja) 2017-02-08
MX347848B (es) 2017-05-16
US20120004302A1 (en) 2012-01-05
WO2012005872A1 (en) 2012-01-12
CA2794129C (en) 2018-05-01
US8815265B2 (en) 2014-08-26
BR112012028648B1 (pt) 2018-02-06
ES2643632T3 (es) 2017-11-23
PL2588460T3 (pl) 2017-12-29
EP2588460A4 (en) 2015-05-06
HK1174628A1 (zh) 2013-06-14
TR201910526T4 (tr) 2019-08-21
TWI552764B (zh) 2016-10-11
JP2013533255A (ja) 2013-08-22
ES2737303T3 (es) 2020-01-13
CN102869649B (zh) 2016-08-03
EP2588460A1 (en) 2013-05-08
TW201206487A (en) 2012-02-16
MX2012014495A (es) 2013-02-21
US9409860B2 (en) 2016-08-09
CA2794129A1 (en) 2012-01-12

Similar Documents

Publication Publication Date Title
IL266168A (en) Heteroaryl compounds and methods of their use
EP2588460A4 (en) COSMETIC USE OF N-SUBSTITUTED SULFONYLOXYBENZYLAMINES AND RELATED COMPOUNDS
IL222227A0 (en) Pyrazol - 4 - heterocyclyl-carboxamide compounds and methods of use
IL247595A0 (en) New modulators and methods of use
SG10202009963PA (en) Melanin modification compositions and methods of use
IL219974A0 (en) Therapeutic compounds and related methods of use
IL226231A0 (en) A formulation of lacosamide that is administered once a day
ZA201301120B (en) Heterocyclic compound and use thereof
SG10201601792UA (en) Novel modulators and methods of use
EP2464227A4 (en) COMPOUNDS AND METHODS OF USE
IL225227A0 (en) Preparations including fulvestrant and methods of use
PL2616062T3 (pl) Stosowanie pochodnych pentapiryny jako środków przeciwdrobnoustrojowych i dezynfekujących
ZA201402758B (en) Brimonidine gel compositions and methods of use
GB201011411D0 (en) Therapeutic compounds and their use
ZA201302952B (en) Fungicidal compositions and methods of use
ZA201300012B (en) Synthesis and use of kinase inhibitors
EP2773343A4 (en) COSMETIC USE OF N-HETEROARYLBISAMIDE ANALOGS AND RELATED COMPOUNDS
GB2478317B (en) Herbicidal composition and method of use thereof
EP2680846A4 (en) USE OF N- (4-METHOXYPHENYL) -1-PHENYL-1H-PYRAZOL-3-AMINE AND COMPOUNDS ASSOCIATED THEREWITH
IL225708A0 (en) Methods for the synthesis of scylitol and related compounds
PL2588073T3 (pl) Kompozycja kosmetyczna dla paznokci i zastosowanie pochodnej izosorbidu
EP2649096A4 (en) HEMOGLOBIN COMPOSITIONS AND METHODS OF USE
SI2574343T1 (sl) Sestavek za nanos na koĹľo in njegova uporaba
GB201020463D0 (en) Herbicidal compositions and methods of use
HU1000688D0 (en) Use of trifluoro-phal